Reykjavik, June 25, 2008

Reykjavik, ICELAND, June 25, 2008 ― deCODE genetics (Nasdaq:DCGN) today announced that it will webcast live the presentations at the company's annual R&D event to be held in New York.

The presentations will be delivered on Monday, June 30, beginning at 1pm Eastern Time/5pm GMT/6pm British Summer time, at the Gansevoort hotel in New York. The webcast is expected to last approximately three and a half hours. The webcast can be accessed through the Investors page on deCODE’s website, www.decode.com or directly at corporate-ir.net, and those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The webcast will be archived for at least one week.

Contacts:
Gisli Arnason                            Joy Bessenger
+354 570 1825                        +1 212 481 3891
gisli.arnason@decode.is            joy.bessenger@decode.is

About deCODE

deCODE genetics (Nasdaq:DCGN) is a global leader in applying human genetics to develop drugs and diagnostics for common diseases. Our population approach has enabled us to discover and target key biological pathways involved in conditions ranging from heart attack to cancer. We are turning these discoveries into new medicine to better treat and prevent many of the biggest challenges to public health. deCODE is delivering on the promise of the new genetics.SM Visit us on the web at www.decode.com.

 

 

Back